Imunon, Inc. (IMNN) stock
IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.61+0.02 (+3.06%)
Close on Nov 17, 2026Market cap $3.44MP/E –Yield –
Imunon total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Imunon's total debt was $4.61M at Dec 31, 2022. For fiscal 2022 it was $4.61M, down 21.2% from the year before. Over ten years it grew 55.3% a year on average. The highest annual figure on record is $9.42M in fiscal 2018.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $4.61M | -21.2% |
| FY2021 | Dec 31, 2021 | $5.85M | +48.8% |
| FY2020 | Dec 31, 2020 | $3.93M | -50.6% |
| FY2019 | Dec 31, 2019 | $7.96M | -15.4% |
| FY2018 | Dec 31, 2018 | $9.42M | +300.7% |
| FY2015 | Dec 31, 2015 | $2.35M | -61.2% |
| FY2014 | Dec 31, 2014 | $6.05M | +21.1% |
| FY2013 | Dec 31, 2013 | $5.00M | +36.6% |
| FY2012 | Dec 31, 2012 | $3.66M | +5013.2% |
| FY2011 | Dec 31, 2011 | $71.60K | +26.9% |
| FY2010 | Dec 31, 2010 | $56.40K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | $4.61M | -21.2% |
| Q3 FY2022 | Sep 30, 2022 | $5.32M | -8.4% |
| Q2 FY2022 | Jun 30, 2022 | $5.95M | +3.2% |
| Q1 FY2022 | Mar 31, 2022 | $5.90M | +81.4% |
| Q4 FY2021 | Dec 31, 2021 | $5.85M | +48.8% |
| Q3 FY2021 | Sep 30, 2021 | $5.81M | +25.5% |
| Q2 FY2021 | Jun 30, 2021 | $5.76M | +2.7% |
| Q1 FY2021 | Mar 31, 2021 | $3.25M | -57.3% |
| Q4 FY2020 | Dec 31, 2020 | $3.93M | -50.6% |
| Q3 FY2020 | Sep 30, 2020 | $4.63M | -49.3% |
| Q2 FY2020 | Jun 30, 2020 | $5.61M | -41.6% |
| Q1 FY2020 | Mar 31, 2020 | $7.62M | -19.9% |
| Q4 FY2019 | Dec 31, 2019 | $7.96M | -15.4% |
| Q3 FY2019 | Sep 30, 2019 | $9.13M | -2.1% |
| Q2 FY2019 | Jun 30, 2019 | $9.61M | +4.2% |
| Q1 FY2019 | Mar 31, 2019 | $9.51M | +621.1% |
| Q4 FY2018 | Dec 31, 2018 | $9.42M | – |
| Q3 FY2018 | Sep 30, 2018 | $9.32M | – |
| Q2 FY2018 | Jun 30, 2018 | $9.22M | – |
| Q1 FY2016 | Mar 31, 2016 | $1.32M | – |
See a number that looks wrong?